Astrana Health Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio35.8928.1029.8447.5717.84
Forward P/E25.0230.6265.7663.3419.86
P/S Ratio0.761.231.184.240.98
P/B Ratio3.014.152.416.421.51
Price/Tangible Book8.846.476.8527.57140.44
Price/FCF35.0742.9822.7764.1514.94
Price/OCF29.6725.0116.4146.6214.56
PEG Ratio2.502.502.502.503.97
Enterprise Value Ratios
EV/Revenue0.731.221.224.191.23
EV/EBITDA12.5916.4811.4628.028.53
EV/EBIT16.5319.9313.3933.0210.48
EV/FCF33.4442.4923.5963.4418.74
Profitability & Returns
Return on Equity (ROE)0.11%0.12%0.09%0.10%0.30%
Return on Assets (ROA)0.05%0.06%0.07%0.07%0.07%
Return on Invested Capital (ROIC)0.10%0.12%0.12%0.13%0.13%
Return on Capital Employed (ROCE)0.09%0.12%0.13%0.13%0.12%
Leverage & Solvency Ratios
Debt/Equity0.920.780.410.400.58
Debt/EBITDA3.642.941.791.672.49
Debt/FCF10.688.093.883.955.79
Liquidity Ratios
Current Ratio1.752.112.883.532.94
Quick Ratio1.682.032.763.332.80
Efficiency Ratios
Asset Turnover1.781.461.250.920.89
Yield & Distribution Ratios
Earnings Yield0.03%0.04%0.03%0.02%0.06%
FCF Yield0.03%0.02%0.04%0.02%0.07%
Payout Ratio1.02%0.31%0.45%1.36%
Buyback Yield-0.02%-0.03%0.00%-0.21%-0.03%